title: Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
authors.affiliation: Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Gettings
authors.affiliation: Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.
authors.forename: Christopher T
authors.initials: CT
authors.lastname: Hackett
authors.affiliation: Department of Neurology, Allegheny General Hospital, Pittsburgh, USA Drexel University College of Medicine, Philadelphia, USA tscott@wpahs.org.
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Scott
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001259:Ataxia / Q000209:etiology; D020233:Gait Disorders, Neurologic / Q000209:etiology; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications*; D010291:Paresis / Q000209:etiology; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab